Antibiotic for Severe Infections in Injection Form has composition of 1000 mg amoxicillin and 200 mg clavulanate potassium. Antibiotic for Severe Infections in Injection Form is manufactured by Windlas Biotech Limited which is WHO -GMP certified company. Windlas Biotech Limited also manufactures various types of pharmaceuticals formulations. The Antibiotic for Severe Infections in Injection Form, under the brand name Wixiclav, is made in automatic line which is terminally sterilized which has filling range of 1ml to 10ml glass ampoule. The Company has highly qualified staff and detailed scheduling processes which ensures quality-minded production, on-time delivery and cost control.